TrueWealth LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

TrueWealth LLC’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$2K	Sell	6 -10	-63%	-$2.71K	﹤0.01%	649
2020 Q1	$4K	Hold	16	–	–	﹤0.01%	588
2019 Q4	$4K	Hold	16	–	–	﹤0.01%	613
2019 Q3	$3K	Hold	16	–	–	﹤0.01%	622
2019 Q2	$3K	Hold	16	–	–	﹤0.01%	635
2019 Q1	$3K	Hold	16	–	–	﹤0.01%	647
2018 Q4	$3K	Hold	16	–	–	﹤0.01%	633
2018 Q3	$3K	Hold	16	–	–	﹤0.01%	699
2018 Q2	$3K	Hold	16	–	–	﹤0.01%	705
2018 Q1	$3K	Sell	16 -13	-45%	-$2.12K	﹤0.01%	670
2017 Q4	$4K	Buy	+29	New	+$4.29K	﹤0.01%	729

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TrueWealth LLC's VRTX Position: Q2 2020 in Review

TrueWealth LLC reduced its Vertex Pharmaceuticals (VRTX) stake by 63% in Q2 2020, selling an estimated $2.71K and leaving 6 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #649.

TrueWealth LLC first reported a position in VRTX in Q4 2017 and has held it in 11 quarters since. The position peaked at $4K in Q1 2020. 964 funds tracked by Wall St. Rank hold VRTX as of Q2 2020.

TrueWealth LLC held 6 shares of Vertex Pharmaceuticals worth $2K as of Q2 2020.
TrueWealth LLC sold 10 Vertex Pharmaceuticals shares in Q2 2020, an estimated $2.71K.
Vertex Pharmaceuticals made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #649 holding.
TrueWealth LLC first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 11 quarters since.
TrueWealth LLC's Vertex Pharmaceuticals position peaked at $4K in Q1 2020.
964 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.